Childhood Leukemia: Overcoming distance between South America and Europe Regions

Informations projet

CLOSER

N° de convention de subvention: 825749

DOI 10.3030/825749

Projet clôturé

Date de signature de la CE 10 Decembre 2018

Date de début 1 Janvier 2019

Date de fin 31 Mars 2024

Financé au titre de

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Coût total € 3 999 601,25

Contribution de l’UE € 3 999 601,25

Coordonné par

HOSPITAL SANT JOAN DE DEU
Spain

Livrables

Documents, reports (1)

Reports on the type and country-specific assessment of MRD technologies in ALL and AML

Reports on the type and countryspecific assessment of MRD technologies in ALL and AML

Publications

Peer reviewed articles (1)

An Extensive Quality Control and Quality Assurance (QC/QA) Program Significantly Improves Inter-Laboratory Concordance Rates of Flow-Cytometric Minimal Residual Disease Assessment in Acute Lymphoblastic Leukemia: An I-BFM-FLOW-Network Report

Auteurs: Margarita Maurer-Granofszky, Angela Schumich, Barbara Buldini, Giuseppe Gaipa, Janos Kappelmayer, Ester Mejstrikova, Leonid Karawajew, Jorge Rossi, Adin Çinar Suzan, Evangelina Agriello, Theodora Anastasiou-Grenzelia, Virna Barcala, Gábor Barna, Drago Batinic, Jean-Pierre Bourquin, Monika Brüggemann, Karolina Bukowska-Strakova, Hasan Burnusuzov, Daniela Carelli, Günnur Deniz, Klara Dubravcic,
Publié dans: Cancers, 2021, ISSN 2072-6694
Éditeur: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/cancers13236148